The Relationship between Platelet Collagen Receptor Glycoprotein VI and No-Reflow Phenomenon in Patients with Acute ST-Segment Elevation Myocardial Infarction

Zhang Q , Zhang RY , Qiu JP , . Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study. Chin Med J (Engl). 2009; 122: 636–642.

Zhang Q , Zhang RY , Qiu JP , . Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Chin Med J (Engl). 2008; 121: 485–491.

Morishima I , Sone T , Mokuno S , . Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J. 1995; 130: 239–243.

Gibson CM , Schömig A . Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation. 2004; 109: 3096–3105.

Kloner RA , Ganote CE , Jennings RB . The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974; 54: 1496–1508.

King SB III , Smith SC Jr , Hirshfeld JW Jr , . 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2008; 51: 172–209.

Gibson CM , Cannon CP , Murphy SA , . Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000; 101: 125–130.

Morishima I , Sone T , Okumura K , . Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000; 36: 1202–1209.

Reffelmann T , Kloner RA . The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006; 101: 359–372.

Ito H . No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006; 3: 499–506.

Rezkalla SH , Kloner RA . Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008; 72: 950–957.

Carden DL , Granger DN . Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000; 190: 255–266.

Xu Y , Huo Y , Toufektsian MC , . Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2006; 290: H692–H699.

Heindl B , Zahler S , Welsch U , . Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts. Cardiovasc Res. 1998; 38: 383–394.

Massberg S , Gawaz M , Grüner S , . A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med. 2003; 197: 41–49.

Nieswandt B , Watson SP . Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003; 102: 449–461.

Moroi M , Jung SM . Platelet glycoprotein VI: its structure and function. Thromb Res. 2004; 114: 221–233.

Wilner GD , Nossel HL , LeRoy EC . Aggregation of platelets by collagen. J Clin Invest. 1968; 47: 2616–2621.

Stephens G , Yan Y , Jandrot-Perrus M , . Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood. 2005; 105: 186–191.

Bergmeier W , Rabie T , Strehl A , . GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost. 2004; 91: 951–958.

Gardiner EE , Arthur JF , Kahn ML , . Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood. 2004; 104: 3611–3617.

Schulz C , Penz S , Hoffmann C , . Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol. 2008; 103: 356–367.

Baumgartner HR . Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with alpha chymotrypsin-digested subendothelium. Thromb Haemost. 1977; 37: 1–16.

Hermiller JB , Cusma JT , Spero LA , . Quantitative and qualitative coronary angiographic analysis: review of methods, utility, and limitations. Cathet Cardiovasc Diagn. 1992; 25: 110–131.

Rentrop KP , Feit F , Sherman W , . Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation. 1989; 80: 1166–1175.

van ‘t Hof AW , Liem A , Suryapranata H , . Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998; 97: 2302–2306.

Gibson CM , de Lemos JA , Murphy SA ., for the TIMI Study Group. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001; 103: 2550–2554.

Killip T III , Kimball JT . Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967; 20: 457–464.

Piana RN , Paik GY , Moscucci M , . Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation. 1994; 89: 2514–2518.

TIMI Study Group . The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985; 312: 932–936.

Al-Tamimi M , Mu FT , Moroi M , . Measuring soluble platelet glycoprotein VI in human plasma by ELISA. Platelets. 2009; 20: 143–149.

Zijlstra F , de Boer MJ , Hoorntje JC , . A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993; 328: 680–684.

Weaver WD , Simes RJ , Betriu A , . Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997; 278: 2093–2098.

Keeley EC , Boura JA , Grines CL . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361: 13–20.

Ito H , Okamura A , Iwakura K , . Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996; 93: 1993–1999.

Reffelmann T , Kloner RA . The “no-reflow” phenomenon: basic science and clinical correlates. Heart. 2002; 87: 162–168.

Cura FA , L'Allier PL , Kapadia SR , ., for the RAPPORT Investigators. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2001; 88: 124–128.

Kaul S , Ito H . Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation. 2004; 109: 310–315.

Iwakura K , Ito H , Ikushima M , . Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003; 41: 1–7.

Topol EJ , Yadav JS . Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000; 101: 570–580.

Heusch G , Schulz R , Baumgart D , . Coronary microembolization. Prog Cardiovasc Dis. 2001; 44: 217–230.

Kotani J , Nanto S , Mintz GS , . Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation. 2002; 106: 1672–1677.

Prati F , Pawlowski T , Gil R , . Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation. 2003; 107: 2320–2325.

Mehran R , Dangas G , Mintz GS , . Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000; 101: 604–610.

Ito H , Tomooka T , Sakai N , . Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992; 85: 1699–1705.

Resnic FS , Wainstein M , Lee MK , . No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003; 145: 42–46.

Eeckhout E , Kern MJ . The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J. 2001; 22: 729–739.

Rezkalla SH , Kloner RA . No-reflow phenomenon. Circulation. 2002; 105: 656–662.

Herrmann J . Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005; 26: 2493–2519.

Kusama I , Hibi K , Kosuge M , . Impact of plaque rupture on infarct size in ST-segment elevation anterior acute myocardial infarction. J Am Coll Cardiol. 2007; 50: 1230–1237.

Frossard M , Fuchs I , Leitner JM , . Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation. 2004; 110: 1392–1397.

Przyklenk K , Kloner RA . “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res. 1989; 64: 86–96.

Golino P , Maroko PR , Carew TE . Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation. 1987; 76: 173–180.

Humphrey SM , Gavin JB , Herdson PB . Catecholamine-depletion and the no-reflow phenomenon in anoxic and ischaemic rat hearts. J Mol Cell Cardiol. 1982; 14: 151–161.

Humphrey SM , Seelye RN , Gavin JB . The influence of adenosine on the no-reflow phenomenon in anoxic and ischaemic hearts. Pathology. 1982; 14: 129–133.

Westin M , Hedén P . Calcitonin gene-related peptide delays the no-reflow phenomenon in the rat island flap. Ann Plast Surg. 1988; 21: 329–334.

Ruggeri ZM . Platelets in atherothrombosis. Nat Med. 2002; 8: 1227–1234.

Kahn ML . Platelet–collagen responses: molecular basis and therapeutic promise. Semin Thromb Hemost. 2004; 30: 419–425.

Cabeza N , Li Z , Schulz C , . Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes. 2004; 53: 2117–2121.

Chen H , Locke D , Liu Y , . The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem. 2002; 277: 3011–3019.

Best D , Senis YA , Jarvis GE , . GPVI levels in platelets: relationship to platelet function at high shear. Blood. 2003; 102: 2811–2818.

Sarratt KL , Chen H , Zutter MM , . GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood. 2005; 106: 1268–1277.

Bigalke B , Lindemann S , Ehlers R , . Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. Eur Heart J. 2006; 27: 2165–2169.

Penz S , Reininger AJ , Brandl R , . Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J. 2005; 19: 898–909.

Gardiner EE , Arthur JF , Berndt MC , . Role of calmodulin in platelet receptor function. Curr Med Chem Cardiovasc Hematol Agents. 2005; 3: 283–287.

Boylan B , Chen H , Rathore V , . Anti–GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood. 2004; 104: 1350–1355.

Gardiner EE , Karunakaran D , Shen Y , . Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost. 2007; 5: 1530–1537.

Nieswandt B , Schulte V , Bergmeier W , . Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. 2001; 193: 459–469.

Massberg S , Konrad I , Bültmann A , . Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J. 2004; 18 (2): 397–399.

Bültmann A , Li Z , Wagner S , . Impact of glycoprotein VI and platelet adhesion on atherosclerosis—a possible role of fibronectin. J Mol Cell Cardiol. 2010; 49: 532–542.

Reininger AJ , Bernlochner I , Penz SM , . A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol. 2010; 55: 1147–1158.